- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01593202
Long Term Efficacy of DBT-A in Adolescents With Repetitive Self-harming and Suicidal Behaviours
Long Term Efficacy of Dialectical Behaviour Therapy vs Enhanced Usual Care for Adolescents With Self-Harming and Suicidal Behaviours
The purpose of the study is to evaluate the long-term efficacy of dialectical behavior therapy (DBT) in treatment of adolescents with deliberate self harm compared to enhanced usual care (EUC). This study follows-up 77 patients in the ages of 12-18 yrs who have been included in an RCT of DBT-A vs EUC. The main inclusion criterion for this study was repetitive self-harm behaviour. The patients were randomly allocated to receive 16 weeks of outpatient DBT or EUC in child and adolescent psychiatric clinics in Oslo. Participants have been assessed so far on five different time-points: baseline (before starting treatment), 9 weeks, 15 weeks, 19 weeks and 71 weeks after start of the treatment. In the current project patients will be assessed a 6th time 2 years after treatment completion.
The main study hypotheses are:
- DBT will be significantly more efficacious in reducing the number of self-harm episodes with or without intent to die, as well as reducing the number of emergency room visits for self-harm or suicidal behaviour, compared to EUC.
- DBT will be significantly more efficacious in reducing the level of suicidal ideation and depressive symptoms compared to EUC.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study is a long-term follow-up of a randomized trial comparing DBT-A with enhanced usual care (EUC). Participants were randomly allocated to receive either treatment at 1 of the participating child and adolescent psychiatric outpatient clinics in a 1:1 ratio stratified according to gender, presence of major depression, and presence of suicide intent during the most serious episode of self-harm behavior within the 16 weeks before enrollment. Treatment allocation of participants after baseline assessments was based on a permuted block randomization procedure with an undisclosed and variable blocking factor, and daily management of the randomization procedures was performed by an external group. Patients received either DBT or EUC by therapists working at and funded by the 10 child and adolescent psychiatric outpatient clinics participating in the study. They were assessed during treatment (9 and 15 weeks), at treatment completion 19 weeks, and at 71 weeks. In this study they are assessed at 2 years after treatment completion.
The assessment of outcomes include: number of self-reported self-harm episodes (suicide attempts and non-suicidal self-harm episodes combined, measured by Lifetime Parasucide Count); the severity of suicidal ideation as measured by the 15-item self-report Suicidal Ideation Questionnaire (SIQ-JR; and level of depressive symptoms as measured by the 13-item version of the self-report Short Mood and Feelings Questionnaire (SMFQ) and through the interviewer rated 10-item Montgomery-_Asberg Depression Rating Scale (MADRS). Other outcomes are hopelessness, measured by the 20-item self-report Beck Hopelessness Scale (BHS);borderline symptoms, assessed through the 23-itemself-report Borderline Symptom List (BSL); Borderline Personality Disorder as measured by SCID-II; and hospital admissions and emergency department visits because of self-harm.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Oslo, Norway, 0372
- National Centre for Suicide Research and Prevention Unit/University of Oslo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Patients included in the initial RCT 'Treatment for Adolescents With Deliberate Self Harm' (ClinicalTrials ID NCT00675129). Inclusion criteria for this study were:
- History of repeated deliberate self harm (last episode within last months)
- Satisfies at least 2 criteria of DSM-IV Borderline Personality Disorder (as measured by SCID-II) in addition to the self-destructive criterion.
Or: Satisfies at least 1 criterion + 2 criteria scored below threshold (score 2) of DSM-IV Borderline Personality Disorder (as measured by SCID-II) in addition to the self-destructive criterion.
Exclusion Criteria:
- Psychotic disorders
- Anorexia Nervosa
- Substance dependence disorder
- Mental retardation (IQ less than 70)
- Asperger syndrome/autism
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Dialectical behavior therapy
Dialectical Behavior Therapy, delivered for 19 weeks, consisted of 1 weekly session of individual therapy (60 minutes), 1 weekly session of multifamily skills training (120 minutes), and family therapy sessions and Telephone coaching with individual therapists outside therapy sessions as needed.
|
16 weeks of Dialectical behavior therapy with one weekly session of individual therapy, one weekly session of multifamily skills training group, telephone coaching and ancillary family therapy and/or pharmacological treatment as needed. The treatment has been developed by Marsha Linehan (Linehan, 1993a; 1993b)and adapted for adolescents by Alec Miller (Miller, Rathus & Linehan, 2007). Individual DBT therapists have been trained by drs Alec L Miller and Sarah K Reynolds and have a minimum of one year clinical practise as DBT therapists. The therapists are organised in two consultation teams supervised on a bimonthly basis throughout the entire study by drs Miller and Reynolds respectively. |
Active Comparator: Enhanced usual care
Enhanced usual care was 19 weeks of standard care (enhanced for the purpose of the study by requiring that EUC therapists agree to provide on average no less than 1 weekly treatment session per patient throughout the trial) delivered by therapists (4 psychiatrists, 16 clinical psychologists, 6 clinical social workers, 2 clinical pedagogues, 1 specialist nurse, and 1 psychology graduate student) not trained in or practicing DBT.
|
16 weeks of outpatient treatment in child and adolescent psychiatric clinics in Oslo, on average one weekly session of individual therapy and ancillary supportive.
family and/or pharmacological treatment as needed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of subsequent episodes of deliberate self harm and time elapsed to future episodes of deliberate self harm
Time Frame: 2 years after end of treatment
|
Measured by the Linehan Parasuicide Count (LPC)
|
2 years after end of treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Severity of suicidal ideation
Time Frame: 2 years
|
Measured by the Suicidal Ideation Questionnaire Jr (SIQ-Jr).
Scale range: min= 0, max = 90.
High values represent a worse outcome.
|
2 years
|
Frequency of subsequent emergency room visits, hospitalizations and use of additional treatments due to risk of deliberate self-harm behavior
Time Frame: 2 years
|
Measured through and interview specifically developed for the purpose and through linkage with the Norwegian Patient Register
|
2 years
|
Self reported level of depressive symptoms
Time Frame: 2 years
|
Measured by the Moods and feelings questionnaire (MFQ).
Scale range: min = 0, max = 26.
High levels represent a worse outcome
|
2 years
|
Researcher rated level of depressive symptoms
Time Frame: 2 years
|
Measured through the Montgomery Asberg Depression Rating Scale (MADRS).
Scale range: min = 0, max = 60.
High levels represent a worse outcome.
|
2 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lars Mehlum, Professor, National Centre for Suicide Research and Prevention
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ES4894
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intentional Self Harm
-
University of Southern MississippiUniversity of UtahCompletedIntentional Self-Harm by Other Specified MeansUnited States
-
Oslo University HospitalCompleted
-
Shanghai Jiao Tong University School of MedicineUnknownSoft Tissue Infections | Intentional Self Harm by Other Specified MeansChina
-
University of OttawaOttawa Hospital Research InstituteWithdrawnSuicide | Intentional Self-HarmCanada
-
University of OttawaOttawa Hospital Research InstituteActive, not recruiting
-
Bournemouth UniversityDorset HealthCare University NHS Foundation TrustNot yet recruiting
-
Pakistan Institute of Living and LearningUniversity of Manchester; Dow University of Health Sciences; Services Hospital... and other collaboratorsCompleted
-
Pakistan Institute of Living and LearningUniversity of ManchesterCompleted
-
University of California, BerkeleyTerminatedSuicidal Ideation | Impulsivity | Deliberate Self-harmUnited States
-
King's College LondonCompletedSelf-Harm, DeliberateUnited Kingdom
Clinical Trials on Dialectical behavior therapy
-
University Hospital, Strasbourg, FranceRecruitingEncephalitis | Meningitis | Acquired Brain Injury | Cerebral Anoxia | Stroke/ Cerebrovascular Accident (Ischemic or Hemorrhagic) | Brain Tumor (After Recovery)France
-
Pontificia Universidad Catolica de ChileUniversity Diego PortalesNot yet recruitingBorderline Personality DisorderChile
-
University of WashingtonNational Institute of Mental Health (NIMH)CompletedSuicide | Post-traumatic Stress Disorder | Self-injurious BehaviorUnited States
-
Fordham UniversityNot yet recruitingAntisocial Personality DisorderUnited States
-
Rutgers, The State University of New JerseyActive, not recruitingBorderline Personality DisorderUnited States
-
University of ManitobaCompletedBorderline Personality DisorderCanada
-
Alexandria UniversityCompleted
-
Evangelisches Krankenhaus Bielefeld gGmbHCompletedBorderline Personality Disorder | Psychotherapy | DropoutGermany
-
Evangelisches Krankenhaus Bielefeld gGmbHCompletedBorderline Personality Disorder | PostTraumatic Stress Disorder | Psychotherapy | DropoutGermany
-
University Hospital, Strasbourg, FranceRecruitingAutism Spectrum DisordersFrance